Gilead Sciences Inc buy Trip
Start price
18.08.20
/
50%
€58.10
Target price
04.11.21
-
Performance (%)
-12.10%
End price
11.11.20
€51.07
Summary
This prediction ended on 11.11.20 with a price of €51.07. The prediction for Gilead Sciences Inc disappointed with a performance of -12.10%. Dividends of €0.57 are taken into consideration when calculating the performance. Trip has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Gilead Sciences Inc | -2.063% | -2.063% | -18.398% | 14.320% |
| iShares Core DAX® | -0.870% | -1.700% | 10.560% | 13.129% |
| iShares Nasdaq 100 | -5.561% | -3.604% | 34.335% | 39.856% |
| iShares Nikkei 225® | -6.138% | -7.732% | 16.215% | 0.044% |
| iShares S&P 500 | -3.141% | -2.011% | 24.534% | 39.859% |
According to Trip what are the pros and cons of Gilead Sciences Inc for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Capable Management
Innovative
Market Leader or Top 3
Small cyclical dependencies
Well known brand
Future proof or reliable business model
Cons
Comments by Trip for this prediction
In the thread Gilead Sciences Inc diskutieren
Buy Gilead Sciences Inc
In the thread Trading Gilead Sciences Inc
Stopped prediction by Trip for Gilead Sciences Inc
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€48.93
05.01.21
05.01.21
-
05.01.22
05.01.22
10.78%
03.06.21
03.06.21
Could be worthwhile Investment >10% per year
Capable Management
Innovative
Market Leader or Top 3
